Concepedia

Irene Hadjiyianni

IH

13

Publications

332

Citations

12

H-Index

2015

Active since

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (Germany)

Analysis Group (United States)

University of California, San Francisco

Forschungsinstitut der Diabetes Akademie Mergentheim

Irene Hadjiyianni is an author at Eli Lilly (United States) specializing in diabetes, metabolic syndrome, and health sciences.

ORCID

Top concepts

Publications per year

2015–2024

13

Publications

13

Real-World Evidence of Omnipod <sup>®</sup> 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes

Gregory P. Forlenza, Daniel J. DeSalvo, Grazia Aleppo et al. · Diabetes Technology & Therapeutics · 2024 · 61 citations · Full text

Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US

Magaly Perez‐Nieves, Samaneh Kabul, Urvi Desai et al. · Current Medical Research and Opinion · 2015 · 46 citations · Full text

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully

William H. Polonsky, Joyce Arsenault, Lawrence Fisher et al. · International Journal of Clinical Practice · 2017 · 41 citations · Full text

Efficacy and safety of <scp>LY2963016</scp> insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine

Irene Hadjiyianni, Dominik Dahl, LB Lacaya et al. · Diabetes Obesity and Metabolism · 2016 · 31 citations · Full text

, , +12

Identifying solutions to psychological insulin resistance: An international study

William H. Polonsky, Lawrence Fisher, Danielle Hessler et al. · Journal of Diabetes and its Complications · 2019 · 29 citations · Full text

Rows per page

1–5 of 13